High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. (Q30432642)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

systemic lupus erythematosus

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

João Luiz Miraglia

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

object named as

Clovis A Silva

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rosa M.R. Pereira

9

object named as

Rosa M R Pereira

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Lucia M A Campos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Adriana A Jesus

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Maria A Ishida

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Cleonice Bueno

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

65

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1121-1127

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Safety of vaccination of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Vaccination and autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Influenza vaccination in patients with rheumatic diseases. Safety and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease

1 reference

https://api.crossref.org/works/10.1002%2FACR.21948

21 January 2018

Identifiers

10.1002/ACR.21948

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818263%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30432642&oldid=2068688858"